US Drug Recall Register
Class II · Moderate risk Terminated Initiated Feb 12, 2015 (12 years ago)

Nifedipine 0.2% - Lidocaine 2% Jelly

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

What was recalled

Nifedipine 0.2% - Lidocaine 2% Jelly, Health Innov Pharmacy, 295 Pinehurst Ave, Southern Pines, NC 28387, (910) 246-5155

Recalling firm
Health Innovations Pharmacy, Inc
Origin
NC, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1045-2015

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Lidocaine recalls

See all
Class II · Moderate risk Ongoing

Xylocaine

Reason Presence of Particulate Matter: Hair was found in products

Fresenius Kabi USA, LLC D-0729-2026
Class II · Moderate risk Ongoing

Xylocaine

Reason Presence of Particulate Matter: Hair was found in products

Fresenius Kabi USA, LLC D-0728-2026
Class II · Moderate risk Ongoing

Lidocaine HCl Injection

Reason Presence of Particulate Matter: Hair was found in products

Fresenius Kabi USA, LLC D-0726-2026
Class III · Low risk Ongoing

Lidolog Kit

Reason Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan

Asclemed USA Inc. D-0713-2026
Class II · Moderate risk Ongoing

Lidocaine HCl Injection USP

Reason Lack of Assurance of Sterility

Asclemed USA Inc. D-0659-2026